LWM
NVO

Lenox Wealth Management’s Novo Nordisk NVO Stock Holding History

Lenox Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$6.26M Buy
191,242
+2,218
+1% +$70.8K 1.91% 8
2020
Q1 		$5.76M Buy
189,024
+30,362
+19% +$904K 1.98% 7
2019
Q4 		$4.59M Sell
158,662
-4,622
-3% -$128K 1.29% 17
2019
Q3 		$4.22M Sell
163,284
-5,244
-3% -$133K 1.23% 19
2019
Q2 		$4.3M Sell
168,528
-3,930
-2% -$97.1K 1.29% 20
2019
Q1 		$4.56M Sell
172,458
-2,694
-2% -$66.2K 1.42% 14
2018
Q4 		$4.04M Sell
175,152
-10,136
-5% -$225K 1.36% 16
2018
Q3 		$4.37M Buy
185,288
+4,520
+3% +$110K 1.3% 15
2018
Q2 		$4.17M Sell
180,768
-38,464
-18% -$914K 1.34% 14
2018
Q1 		$5.46M Buy
219,232
+2,946
+1% +$77.3K 1.76% 10
2017
Q4 		$5.8M Buy
216,286
+31,502
+17% +$801K 1.76% 10
2017
Q3 		$4.45M Buy
184,784
+43,888
+31% +$992K 1.53% 8
2017
Q2 		$3.02M Buy
+140,896
New +$2.84M 1.23% 9

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Lenox Wealth Management's NVO Position: Q2 2020 in Review

Lenox Wealth Management increased its Novo Nordisk (NVO) stake by 1.2% in Q2 2020, buying an estimated $70.8K and bringing the position to 191,242 shares worth $6.26M. The position accounts for 1.91% of the portfolio, ranked #8.

Lenox Wealth Management first reported a position in NVO in Q2 2017 and has held it in 13 quarters since. 660 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

  • Lenox Wealth Management held 191,242 shares of Novo Nordisk worth $6.26M as of Q2 2020.
  • Lenox Wealth Management bought 2,218 Novo Nordisk shares in Q2 2020, an estimated $70.8K.
  • Novo Nordisk made up 1.91% of Lenox Wealth Management's portfolio in Q2 2020, its #8 holding.
  • Lenox Wealth Management first reported a position in Novo Nordisk in Q2 2017 and has held it in 13 quarters since.
  • 660 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.